New Key Statistics Module, Z-Score and F-Score
NAS:ASND Key Ratios
| Market Cap $ M | 8,390.54 |
| Enterprise Value $ M | 8,624.83 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 22.33 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 357.00 |
| EPS (TTM) $ | -8.14 |
| Beneish M-Score | -3 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -18.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -27.62 |
| EV-to-EBITDA | -28.95 |
| PEG | -- |
| Shares Outstanding M | 59.80 |
| Net Margin (%) | -130.13 |
| Operating Margin % | -96.31 |
| Pre-tax Margin (%) | -127.22 |
| Quick Ratio | 0.84 |
| Current Ratio | 1.16 |
| ROA % (ttm) | -49.11 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -50.22 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.10 |
ASND Number of Guru Trades
ASND Volume of Guru Trades
Gurus Latest Trades with NAS:ASND
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ASND is held by these investors
Total 1
Ascendis Pharma AS Insider Transactions
No Available Data
News about NAS:ASND
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers